SIRT1 and amyotrophic lateral sclerosis: QCN reduces the pathogenesis of ALS by inhibiting inflammation and endoplasmic reticulum (ER) stress through activation the neuroprotective signaling proteins, including Sirtuin 1 (SIRT1), AMP-activated protein kinase (AMPK), and sestrin 2 (Jin et al. 2023).